Table 2.
Clinical trials about the use of azithromycin in patients with CF.
| Goal of the Clinical Trials | ClinicalTrials.gov Identifier | Study Phase | Status | Results | Country |
|---|---|---|---|---|---|
| Continuous Azithromycin in CF patients beyond two years (AZITHRO) | NCT02803944 | Phase 4 | Completed | Not available | France |
| Effect of Azithromycin on Lung Function in 6-18 years old with CF Not Infected with P. aeruginosa | NCT00431964. | Phase 4 | Completed | Available | EEUU |
| Scandinavian CF Azithromycin Study | NCT00411736 | Phase 4 | Completed | Not available | Denmark Norway Sweden |
| Effect of Azithromycin on Fatty Acids in CF | NCT03045198 | Phase 4 | Unknown | Not available | Germany |
| Testing the effect of adding chronic oral azithromycin to inhaled tobramycin in people with CF (TEACH) | NCT02677701. | Phase 4 | Completed | Not available | USA |
| Azithromycin in patients with CF, infected with Burkholderia cepacia complex | NCT00298922 | Phase 2 | Unknown | Not available | Canada |
| Prevention of bronchiectasis in infants with CF (COMBATCF) | NCT01270074 | Phase 3 | Active | Not available | USA |
| OPTIMIZing treatment for early Pseudomonas aeruginosa infection in Cystic Fibrosis. | NCT02054156 | Phase 3 | Completed | Available | USA |